Skip to main content
NCBI home page
The Journal of Hygiene logoLink to The Journal of Hygiene
. 1986 Apr;96(2):305–333. doi: 10.1017/s0022172400066079

Quantitative investigations of different vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom.

R M Anderson, B T Grenfell
PMCID: PMC2129652  PMID: 3701044

Abstract

The paper examines predictions of the impact of various one-, two- and three-stage vaccination policies on the incidence of congenital rubella syndrome (CRS) in the United Kingdom with the aid of a mathematical model of the transmission dynamics of rubella virus. Parameter estimates for the model are derived from either serological data or case notifications, and special attention is given to the significance of age-related changes in the rate of exposure to rubella infection and heterogeneous mixing between age groups. Where possible, model predictions are compared with observed epidemiological trends. The principal conclusion of the analyses is that benefit is to be gained in the UK, both in the short and long term, by the introduction of a multiple-stage vaccination policy involving high levels of vaccination coverage of young male and female children (at around two years of age) and teenage girls (between the ages of 10-15 years), plus continued surveillance and vaccination of adult women in the child-bearing age classes. Model predictions suggest that to reduce the incidence of CRS in future years, below the level generated by a continuation of the current UK policy (the vaccination of teenage girls), would require high rates of vaccination (greater than 60%) of both boys and girls at around two years of age. Numerical studies also suggest that uniform vaccination coverage levels of greater than 80-85% of young male and female children could, in the long term (40 years or more), eradicate rubella virus from the population. The robustness of these conclusions with respect to the accuracy of parameter estimates and various assumptions concerning the pattern of age-related change in exposure to infections and 'who acquires infection from whom' is discussed.

Full text

PDF
305

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson R. M., Grenfell B. T., May R. M. Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis. J Hyg (Lond) 1984 Dec;93(3):587–608. doi: 10.1017/s0022172400065177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Anderson R. M., May R. M. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg (Lond) 1985 Jun;94(3):365–436. doi: 10.1017/s002217240006160x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anderson R. M., May R. M. Directly transmitted infections diseases: control by vaccination. Science. 1982 Feb 26;215(4536):1053–1060. doi: 10.1126/science.7063839. [DOI] [PubMed] [Google Scholar]
  4. Anderson R. M., May R. M. Spatial, temporal, and genetic heterogeneity in host populations and the design of immunization programmes. IMA J Math Appl Med Biol. 1984;1(3):233–266. doi: 10.1093/imammb/1.3.233. [DOI] [PubMed] [Google Scholar]
  5. Anderson R. M., May R. M. Two-stage vaccination programme against rubella. Lancet. 1983 Dec 17;2(8364):1416–1417. doi: 10.1016/s0140-6736(83)90939-x. [DOI] [PubMed] [Google Scholar]
  6. Anderson R. M., May R. M. Vaccination against rubella and measles: quantitative investigations of different policies. J Hyg (Lond) 1983 Apr;90(2):259–325. doi: 10.1017/s002217240002893x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. BLACK F. L. Measles antibodies in the population of New Haven, Connecticut. J Immunol. 1959 Jul;83(1):74–82. [PubMed] [Google Scholar]
  8. Field A. M. The occurrence of neutralizing and complement fixing antibodies in rubella. J Hyg (Lond) 1967 Sep;65(3):409–421. doi: 10.1017/s0022172400045927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fine P. E., Clarkson J. A. Distribution of immunity to pertussis in the population of England and Wales. J Hyg (Lond) 1984 Feb;92(1):21–36. doi: 10.1017/s0022172400063993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fine P. E., Clarkson J. A. Measles in England and Wales--I: An analysis of factors underlying seasonal patterns. Int J Epidemiol. 1982 Mar;11(1):5–14. doi: 10.1093/ije/11.1.5. [DOI] [PubMed] [Google Scholar]
  11. Fine P. E., Clarkson J. A. Measles in England and Wales--II: The impact of the measles vaccination programme on the distribution of immunity in the population. Int J Epidemiol. 1982 Mar;11(1):15–25. doi: 10.1093/ije/11.1.15. [DOI] [PubMed] [Google Scholar]
  12. Grenfell B. T., Anderson R. M. The estimation of age-related rates of infection from case notifications and serological data. J Hyg (Lond) 1985 Oct;95(2):419–436. doi: 10.1017/s0022172400062859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hethcote H. W. Measles and rubella in the United States. Am J Epidemiol. 1983 Jan;117(1):2–13. doi: 10.1093/oxfordjournals.aje.a113511. [DOI] [PubMed] [Google Scholar]
  14. Knox E. G. Strategy for rubella vaccination. Int J Epidemiol. 1980 Mar;9(1):13–23. doi: 10.1093/ije/9.1.13. [DOI] [PubMed] [Google Scholar]
  15. Miller E., Cradock-Watson J. E., Pollock T. M. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet. 1982 Oct 9;2(8302):781–784. doi: 10.1016/s0140-6736(82)92677-0. [DOI] [PubMed] [Google Scholar]
  16. Nokes D. J., Anderson R. M., Anderson M. J. Rubella epidemiology in South East England. J Hyg (Lond) 1986 Apr;96(2):291–304. doi: 10.1017/s0022172400066067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. O'Shea S., Best J. M., Banatvala J. E., Marshall W. C., Dudgeon J. A. Persistence of rubella antibody 8-18 years after vaccination. Br Med J (Clin Res Ed) 1984 Apr 7;288(6423):1043–1043. doi: 10.1136/bmj.288.6423.1043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. O'Shea S., Best J. M., Banatvala J. E., Marshall W. C., Dudgeon J. A. Rubella vaccination: persistence of antibodies for up to 16 years. Br Med J (Clin Res Ed) 1982 Jul 24;285(6337):253–255. doi: 10.1136/bmj.285.6337.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Schenzle D. An age-structured model of pre- and post-vaccination measles transmission. IMA J Math Appl Med Biol. 1984;1(2):169–191. doi: 10.1093/imammb/1.2.169. [DOI] [PubMed] [Google Scholar]
  20. South M. A., Sever J. L. Teratogen update: the congenital rubella syndrome. Teratology. 1985 Apr;31(2):297–307. doi: 10.1002/tera.1420310216. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Hygiene are provided here courtesy of Cambridge University Press

RESOURCES